Strategies for cancer prevention generally come from observational epidemiology and must include monitoring for the effects of the actions. The measurement-iterative loop allows us to refine our approach to cancer prevention. When available, clinical trials can also provide strategies for control. Exposure-specific strategies are described; these are such things as health promotion and behavior modification, legislative approaches, treatment for addiction, changes in the food supply, chemoprevention, occupational and environmental regulation, immunization, identification of persons with enhanced genetic susceptibility, and improved surveillance systems. For some exposures such as tobacco, zero exposure is the goal. For others, prudent avoidance or exposures as low as reasonably achievable are appropriate approaches. Research on how to impact deeply ingrained lifestyle and cultural factors has high priority. -Environ Health Perspect 103(Suppl 8): 313-317 (1995) 
Introduction
In his introductory remarks to this conference, Dr. Samuel Broder indicated that we need clinical trials to guide us in our strategies for action. It is clear, however, that we cannot expect to have clinical trial data to guide us in all our approaches to the prevention of cancer. We need to combine data from observational epidemiology with monitoring of the effect of our actionsthe measurement-iterative loop ( Figure 1 ). This approach will enable us to take corrective actions when necessary to refine our approach to cancer prevention.
Tobacco
Tobacco carcinogenesis is well accepted. Except for a few cancers, we must concentrate our efforts on control by a combination of health promotion and legislative approaches; approaches must be taken in concert with approaches to the control of cardiovascular and chronic respiratory diseases and improved maternal and child health. Our recent experience in Canada, however, indicates how disease may clash with political rea smuggling issue, which clashes v nal interests, commercial an realities, may yet turn to our advantage, however. Smoking ] socially unacceptable in the dominant culture, and trends are in motion that seem inevitable, although, as Dr. Ernst Wynder emphasized (1), we still need to better understand the sociological determinants of smoking (a major research requirement, especially among children and adolescents), and how we can effectively intervene.
Additional research is still required into the determinants of quitting smoking, and how this may be accelerated in the general population by public health approaches that are realistic within the present financial climate.
Dr. Tracy Orleans emphasized the approaches to treatment of nicotine addiction (2) 
Hormones and Medications
The area of hormones and medications is one in which there are likely to be tradeoffs between the adverse effects of cancer and overall health benefits. For those circumstances in which hormone use reduces cancer risk (e.g., combined oral contraceptives and endometrial and ovarian cancer), the benefits clearly outweigh the risks, even with increases in breast and liver cancer, except possibly for heavy cigarette smokers. But for estrogen replacement therapy, we have incomplete evidence, especially with regard to lifelong risks and benefits for noncancer conditions such as those related to bone and cardiovascular disease, particularly when estrogens are combined with progestins. As Dr. Malcolm Pike emphasized, women must be sufficiently informed to make their decisions. There is a problem related to the nature of the information currently given, however, especially by some professional groups such as gynecolo-
gists. An important prevention research issue, therefore, is to develop better mechanisms to understand the overall risks and benefits.
A prevention trial is under way-the tamoxifen trial-that asks a valid question that will give us information on etiology, but will not necessarily result in a viable public health intervention. The Women's Health Initiative will also produce relevant data, although Dr. Barbara Hulka has reservations about the power of this study to be fully informative in this area (4) . Not discussed was a similar trial of finasteride, an inhibitor of the enzyme that converts testosterone to dihydrotestosterone, the principal androgen responsible for normal and hyperplastic growth of the prostate gland. The drug has already been found to relieve symptoms of benign adenomatous hyperplasia of the prostate (BAHP) and to shrink the prostate gland. A prevention trial of 18,000 men, given either finasteride or a placebo for 7 years and followed for life, is planned by the National Cancer Institute (NCI). Given the possible benefit for BAHP, this could, in practice, have wider application than tamoxifen among women.
Medications Of the bacterial agents, only Helicobacter pylori appears to be a potential cause of cancer of the stomach, although large bowel flora may be part of the causal chain in the development of colon cancer. On the assumption that treating H. pylori infection with antibiotics would reduce the risk of stomach cancer by 30%, the cost effectiveness of such an approach seems high. Dr. Julie Parsonnet suggests the cost to be $70,000 per year of life gained compared with $5,000 for mammography and breast cancer. Clearly, more definitive etiologic data are required before screening for infection and treatment will be justifiable in North America.
Gender, Ethnicity, and Environment
Sociological evaluation of cultural differences that have an impact on acceptance of cancer prevention interventions requires further emphasis. Poverty and lifestyle are likely to be more important than ethnicity, although genetic differences may be involved and should not be overlooked. Indeed, they may be emphasized shortly by the identification of differing genetically related susceptibilities to carcinogen-metabolizing enzymes that may well vary by ethnicity. The environment, both social and physical, may have an adverse impact on the effectiveness of prevention.
Although, in general, we know as much about cancer prevention in women as in men, there are obvious gaps in our knowledge such as cancer risk among white women in certain occupations and minorities in most circumstances. Small numbers of subjects and thus of cancers may pose difficulties for epidemiologic studies that require multicenter studies, or special analyses of subgroups in many studies followed by pooled analysis.
Some lifestyle factors recognized as relevant in cancer prevention (e.g., dietary habit and nonsmoking) may be more prevalent among certain minority populations than in the population in general. There is a need to reinforce such behaviors in these minority populations and extend them to the general population.
Genetic Susceptibilities and Environmental Interactions
Genetic-environmental interactions are important in cancer etiology and must be considered in cancer prevention. It seems likely that all cancers have a genetic basis, although few of these appear to be transmitted in ways to increase cancer risk (i.e., to induce hereditary cancer). In terms of the genetic changes that underly cancer induction by environmental factors, there may be relatively few critical oncogenes and tumor suppressor genes, so hope is increasing for cancer therapy and for identification of markers for early detection, although it is not yet clear whether they actually have a role in cancer prevention.
p53 (the most important of the tumor suppressor genes so far identified) may be relevant in 50% of human cancers. Inherited abnormalities of p53 have been identified in a few families with increased risk of breast cancer, although p53 does not seem to have a major role in breast cancer (abnormalities of p53 are detectable only in about 30% of breast cancer cases). It is now clear that discrete mutations of p53 can be induced by exogenous factors (e.g., carcinogens such as aflatoxin, cigarette smoke, radon, and vinyl chloride) as well as by endogenous factors.
For inherited genetic factors, we must remember that the inherited genes are just the first hit. The second hit, the process that starts carcinogenesis, comes from environmental factors. Identifying these factors will probably be facilitated by being able to identify those women and men at increased risk in the population, particularly those in families that appear to be transmitting particular genetic changes.
Genetic research raises the likelihood that some day we will be able to identify persons who are particularly susceptible to the effects of environmental carcinogens. Whether such susceptibility will be shown to be largely inherited or in most instances acquired is quite uncertain at present even though the acquired susceptibilities are shown to have a genetic basis. The susceptibilities so far identified are largely related to differences between individuals in the metabolism of carcinogens. These appear to be particularly important in increasing risk in those experiencing low levels of exposure to the carcinogens. Combinations of genes that influence metabolism are likely to be shown to be most important.
Genetic screening raises many concerns. Although those potentially at risk who are found to be negative to the genetic marker tested will be reassured, there may be concern about false reassurance if the test is not 100% specific (and, so We must quantify the size of the problem, assess results of interventions, and maintain high-quality surveillance systems. Poverty (lack of education) can be regarded as a carcinogen, although it is not always advantageous to be rich. Dispersion theory recognizes that some habits are taken up first by the rich and then by the poor, as exhibited by the changing social class risks for lung cancer and the diet-associated cancers.
The list of avoidable cancers is long, headed by lung but closely followed by the other tobacco-associated cancers (oropharynx, larynx, esophagus, pancreas, bladder, kidney, and perhaps, cervix) and the dietassociated cancers (breast, colon, prostate, stomach, rectum, and pancreas, as well as lung and bladder). The overlap between these lists emphasizes both the interaction between different factors and the fact that the proportion of cancer attributable, and even more so the proportion attributable to individual factors, is controversial, although we have to bear in mind the time it takes to have full impact on the population. However, if the cancers caused by alcohol and known occupational hazards and sunlight are added, it seems clear that current knowledge theoretically permits avoidance of over 50% of our current cancer burden, if not more.
If it is preventable, why is it not prevented? The major gap in our knowledge is not about causes of cancer on which we can intervene now but the difficulty in achieving any impact on deeply ingrained lifestyle and cultural factors. Research into this area, as identified above, has very high priority for a number of factors.
Needs for the Future
For cancer prevention, a cautionary principle is in order: "Try not to do things that have unwelcome consequences. We do not Environmental Health Perspectives want to be wrong too far in the wrong direction," i.e., prudent avoidance. For ionizing radiation, the as low as reasonably achievable (ALARA) principle is well accepted. For tobacco smoking, zero exposure is the legitimate goal, but for many other known or suspect carcinogens, the ALARA principle may be the only appropriate, if not acceptable, approach.
We need new tools for exposure assessment, new approaches for studying complex mixtures, improved surveillance methods, and more qualified investigators who are able to combine biology with epidemiology in a collaborative multidisciplinary mode. However, the main need at present is to evaluate the success of what is being done, and in accordance with the measurement-iterative loop principle, increase the effectiveness and efficiency of the interventions that are applied to the general population.
Government has a role, and it is important to ensure consistency of policies, which clearly is not the case for tobacco, and possibly not for diet and other factors. This is partly a need for public health policy research, but also partly a function of effective leadership at the highest and at the cabinet levels. If government really wishes to promote human health, it should demonstrate to the public that it is serious, and carefully evaluate the health consequences of all government actions as well as the economic consequences. If economic factors predominate, the government should make this clear; if political, as in the tobacco taxation issue, this should also be made explicit. Then the public will be able to decide whether their representatives are carrying out their mandate in accordance with their wishes and act accordingly.
